Skip to content
Clinical Trials – home
Research site

Umhat Sveta Marina - Pleven OOD

Bulgaria Bulgarian Aviation Street 1, 5800 Pleven, Bulgaria

  • 2 trials recruiting
  • Non-small cell lung cancer · Metabolic dysfunction-associated liver disease
  • Adult patients

About Specializations

Umhat Sveta Marina - Pleven OOD in Pleven, Bulgaria specialises in clinical trials of conditions such as Non-small cell lung cancer, Metabolic dysfunction-associated liver disease, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology – Advanced Lung Cancer

In the Department of Medical Oncology, researchers are evaluating novel targeted agents for KRAS p.G12C positive non‑small cell lung cancer.

  • Targeted KRAS inhibition
  • Combination chemo‑immunotherapy
  • Survival outcome assessment

The study compares sotorasib combined with chemotherapy to pembrolizumab‑based regimens, aiming to improve progression‑free survival and overall outcomes for patients with advanced disease.

Metabolic Diseases – Liver Health

A dedicated program investigates therapeutic strategies for Metabolic Dysfunction‑Associated Steatotic Liver Disease.

  • Multi‑agent metabolic protocols
  • Outcome‑focused liver assessments
  • Reduction of major adverse liver events

Conducted at Umhat Sveta Marina - Pleven OOD, the master protocol evaluates several agents to determine whether the new approach can lower the incidence of serious liver complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bulgarian Aviation Street 15800 PlevenBulgaria
Recruiting now
2 trials
Conditions studied
2

More sites in PlevenBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ly3437943 Sodium
  • Sponsor:Eli Lilly & Co.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.